Acetylsalicylic Acid + Rivaroxaban Interaction
Majorinteraction on record
Description
Platelet aggregation inhibitor coadministration may increase bleeding risk. Promptly evaluate signs/symptoms of blood loss.
Source: NLP:rivaroxaban
Platelet aggregation inhibitor coadministration may increase bleeding risk. Promptly evaluate signs/symptoms of blood loss.
Source: NLP:rivaroxaban